Retatrutide 30 mg | Kit with 3 mL Bacteriostatic Water

What Is Retatrutide?

Retatrutide (LY3437943) is an investigational molecule developed to simultaneously activate three hormone receptors: GLP-1, GIP, and glucagon.

Its mechanism of action has attracted scientific interest because of its involvement in metabolic processes, glucose regulation, and energy balance.

Retatrutide remains under investigation in clinical trials.

Key Research Areas

1. Body Weight Regulation

Retatrutide is being studied in clinical trials evaluating its effects on body weight and various parameters associated with obesity and overweight.

2. Glucose Metabolism

Research is exploring its effects on mechanisms related to glycemic control, hormonal responses, and energy metabolism, particularly in individuals with type 2 diabetes.

3. Metabolic Health

Clinical studies are investigating its potential applications in metabolic conditions, including metabolic dysfunction-associated steatotic liver disease.

Product Specifications

• Product Name: Retatrutide
• Scientific Identifier: LY3437943
• Compound Type: Triple GIP, GLP-1, and glucagon receptor agonist
• Declared Content: 10 mg
• Physical Form: Powder
• Presentation: 2-vial kit
• Vial 1: Retatrutide powder, 30 mg
• Vial 2: Bacteriostatic water, 3 mL
• Category: Research Peptides
• Important Information

Retatrutide is an investigational compound whose safety and efficacy remain under clinical evaluation.

The research areas described above do not establish the therapeutic efficacy of this specific product.

For research purposes only. Not approved for human therapeutic administration or for the treatment, prevention, or cure of any disease.